Home > Research > Publications & Outputs > Effector Tregs

Research

Associated organisational unit

Electronic data

  • 4686-63757-3-PB

    Rights statement: All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.

    Final published version, 538 KB, PDF document

    Available under license: CC BY

Links

Text available via DOI:

Keywords

View graph of relations

Effector Tregs: middle-men in TGFβ activation

Research output: Contribution to Journal/Magazine › Editorial › peer-review

Published

Standard

Effector Tregs: middle-men in TGFβ activation. / Worthington, John J.; Travis, Mark A.
In: Oncotarget, Vol. 6, No. 24, 27.06.2015, p. 19958-19959.

Research output: Contribution to Journal/Magazine › Editorial › peer-review

Harvard

Worthington, JJ & Travis, MA 2015, 'Effector Tregs: middle-men in TGFβ activation', Oncotarget, vol. 6, no. 24, pp. 19958-19959. https://doi.org/10.18632/oncotarget.4686

APA

Worthington, J. J., & Travis, M. A. (2015). Effector Tregs: middle-men in TGFβ activation. Oncotarget, 6(24), 19958-19959. https://doi.org/10.18632/oncotarget.4686

Vancouver

Worthington JJ, Travis MA. Effector Tregs: middle-men in TGFβ activation. Oncotarget. 2015 Jun 27;6(24):19958-19959. doi: 10.18632/oncotarget.4686

Author

Worthington, John J. ; Travis, Mark A. / Effector Tregs : middle-men in TGFβ activation. In: Oncotarget. 2015 ; Vol. 6, No. 24. pp. 19958-19959.

Bibtex

@article{1369f595b6794f5cb640dcf5edd18122,
title = "Effector Tregs: middle-men in TGFβ activation",
keywords = "Immunology and Microbiology Section, Immune response, Immunity, regulatory T-cells, inflammatory bowel disease, integrins, transforming growth factor β",
author = "Worthington, {John J.} and Travis, {Mark A.}",
year = "2015",
month = jun,
day = "27",
doi = "10.18632/oncotarget.4686",
language = "English",
volume = "6",
pages = "19958--19959",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "24",

}

RIS

TY - JOUR

T1 - Effector Tregs

T2 - middle-men in TGFβ activation

AU - Worthington, John J.

AU - Travis, Mark A.

PY - 2015/6/27

Y1 - 2015/6/27

KW - Immunology and Microbiology Section

KW - Immune response

KW - Immunity

KW - regulatory T-cells

KW - inflammatory bowel disease

KW - integrins

KW - transforming growth factor β

U2 - 10.18632/oncotarget.4686

DO - 10.18632/oncotarget.4686

M3 - Editorial

C2 - 26158637

VL - 6

SP - 19958

EP - 19959

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 24

ER -